Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-01 6:34 pm Unchanged | 2022-02-01 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 0 (Unchanged) | Filing History |
| 2022-02-01 1:48 pm Purchase | 2021-12-31 | 13G | Innoviva, Inc. INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,683,485 5.300% | 3,683,485 (New Position) | Filing History |
| 2022-01-28 1:54 pm Sale | 2021-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 9,008,758 13.000% | -2,151,788 (-19.28%) | Filing History |
| 2021-11-01 09:27 am Purchase | 2021-10-28 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 30,941,416 73.800% | 30,941,416 (New Position) | Filing History |
| 2021-06-11 5:37 pm Purchase | 2021-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 75.500% | 29,345,794 (+104.81%) | Filing History |
| 2021-06-07 4:43 pm Sale | 2021-05-31 | 13G | Innoviva, Inc. INVA | Renaissance Technologies LLC | 7,491,342 10.790% | -390,460 (-4.95%) | Filing History |
| 2021-05-25 5:05 pm Unchanged | 2021-05-25 | 13D | Innoviva, Inc. INVA | Sarissa Capital Management LP | 6,414,000 9.240% | 0 (Unchanged) | Filing History |
| 2021-05-25 4:24 pm Sale | 2021-05-20 | 13D | Innoviva, Inc. INVA | GSK plc | 0 0.000% | -32,005,260 (Position Closed) | Filing History |
| 2021-05-03 5:19 pm Purchase | 2021-05-03 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 44,807,844 70.600% | 7,462,050 (+19.98%) | Filing History |
| 2021-04-05 5:07 pm Sale | 2021-04-01 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 0 0.000% | -29,729,294 (Position Closed) | Filing History |
| 2021-03-17 5:17 pm Purchase | 2021-03-17 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 29,729,294 74.700% | 8,571,870 (+40.51%) | Filing History |
| 2021-02-12 5:13 pm Unchanged | 2021-02-12 | 13D | Innoviva, Inc. INVA | GSK plc | 32,005,260 31.600% | 0 (Unchanged) | Filing History |
| 2021-02-11 09:42 am Sale | 2020-12-31 | 13G | Innoviva, Inc. INVA | Renaissance Technologies LLC | 7,881,802 7.770% | -11,895 (-0.15%) | Filing History |
| 2021-02-10 11:03 am Sale | 2020-12-31 | 13G | Innoviva, Inc. INVA | The Vanguard Group | 6,595,483 6.500% | -211,456 (-3.11%) | Filing History |
| 2021-01-27 5:30 pm Purchase | 2021-01-26 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 21,157,424 68.000% | 3,735,824 (+21.44%) | Filing History |
| 2021-01-26 6:52 pm Sale | 2020-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 11,160,546 11.000% | -337,500 (-2.94%) | Filing History |